Effective from
- Inherited rules changed
Malignant neoplasm of endocrine pancreas
Billable diagnosis code
CDC/NCHS · FY2022code to identify any functional activity.
if applicable exocrine pancreatic insufficiency (K86.81)
Kaposi's sarcoma of gastrointestinal sites (C46.4)
gastrointestinal stromal tumors (C49.A-)
Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗Grouping depends on the complete encounter and CMS grouper logic.
2026-04-01 – 2026-09-30
CMS · MS-DRG 43.1First observed · 2015-10-01
Latest recorded change · FY2022
Effective from
Malignant neoplasm of endocrine pancreas
Billable diagnosis code
CDC/NCHS · FY2022| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Inherited rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Inherited rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical mapping only; not an automatic code substitution.
Malignant neoplasm of islets of Langerhans
code to identify any functional activity.
if applicable exocrine pancreatic insufficiency (K86.81)
Kaposi's sarcoma of gastrointestinal sites (C46.4)
gastrointestinal stromal tumors (C49.A-)
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| C25.0 | Malignant neoplasm of head of pancreas | Billable / specific |
| C25.1 | Malignant neoplasm of body of pancreas | Billable / specific |
| C25.2 | Malignant neoplasm of tail of pancreas | Billable / specific |
| C25.3 | Malignant neoplasm of pancreatic duct | Billable / specific |
| C25.7 | Malignant neoplasm of other parts of pancreas | Billable / specific |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas | Billable / specific |
| C25.9 | Malignant neoplasm of pancreas, unspecified | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗